Tirzepatide as a novel therapeutic option for patients with type 2 diabetes: A pooled analysis of subgroups of SURPASS 1-5 trials

MLA

Mohammed Altigani Abdalla, et al. “Tirzepatide as a Novel Therapeutic Option for Patients with Type 2 Diabetes: A Pooled Analysis of Subgroups of SURPASS 1-5 Trials.” Journal of Diabetology, vol. 14, Jan. 2023, pp. 65–73. EBSCOhost, https://doi.org/10.4103/jod.jod_16_23.

APA

Mohammed Altigani Abdalla, Ireneous Soyiri, Stephen Atkin, & Thozhukat Sathyapalan. (2023). Tirzepatide as a novel therapeutic option for patients with type 2 diabetes: A pooled analysis of subgroups of SURPASS 1-5 trials. Journal of Diabetology, 14, 65–73. https://doi.org/10.4103/jod.jod_16_23

Chicago

Mohammed Altigani Abdalla, Ireneous Soyiri, Stephen Atkin, and Thozhukat Sathyapalan. 2023. “Tirzepatide as a Novel Therapeutic Option for Patients with Type 2 Diabetes: A Pooled Analysis of Subgroups of SURPASS 1-5 Trials.” Journal of Diabetology 14 (January): 65–73. doi:10.4103/jod.jod_16_23.